Compare AWK & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AWK | WAT |
|---|---|---|
| Founded | 1886 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.2B | 22.5B |
| IPO Year | 2008 | 1995 |
| Metric | AWK | WAT |
|---|---|---|
| Price | $130.97 | $376.32 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 15 |
| Target Price | $142.10 | ★ $390.67 |
| AVG Volume (30 Days) | ★ 2.4M | 632.3K |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | ★ 2.54% | N/A |
| EPS Growth | ★ 13.02 | 3.82 |
| EPS | 5.69 | ★ 10.88 |
| Revenue | ★ $5,070,000,000.00 | $3,105,638,000.00 |
| Revenue This Year | $9.16 | $7.96 |
| Revenue Next Year | $6.81 | $6.32 |
| P/E Ratio | ★ $22.89 | $34.76 |
| Revenue Growth | ★ 12.29 | 6.90 |
| 52 Week Low | $118.74 | $275.05 |
| 52 Week High | $155.50 | $423.56 |
| Indicator | AWK | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 42.31 |
| Support Level | $131.58 | $372.93 |
| Resistance Level | $134.64 | $397.55 |
| Average True Range (ATR) | 2.66 | 9.27 |
| MACD | 0.45 | -4.19 |
| Stochastic Oscillator | 36.03 | 6.20 |
American Water Works is the largest investor-owned US water and wastewater utility, serving nearly 4 million customers in 14 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's nonregulated business is water services for military bases, which operates under long-term contracts with regulated-like returns. The proposed Essential Utilities acquisition would add regulated water and wastewater utilities in Ohio, North Carolina, and Texas while increasing its presence in Illinois, Indiana, Pennsylvania, New Jersey, and Virginia.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.